Pharmaceutical Preparations · DE · CIK 1658551
Develops novel therapies for endocrine conditions and neurodegenerative diseases, focusing on avexitide for hypoglycemia
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 1 insider bought $101K · 5 sold $5.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Cohen Joshua BCo-Chief Executive Officer | Sell | 29,282 | $14.48 | $424K |
| Mar 2, 2026 | Klee Justin B.Co-Chief Executive Officer | Sell | 29,282 | $14.47 | $424K |
| Mar 2, 2026 | Frates James MChief Financial Officer | Sell | 7,909 | $14.52 | $115K |
| Mar 2, 2026 | Mazzariello GinaChief Legal Officer | Sell | 6,844 | $14.52 | $99K |
| Mar 2, 2026 | Bedrosian Camille LChief Medical Officer | Sell | 6,461 | $14.58 | $94K |
| Feb 23, 2026 | Mazzariello GinaChief Legal Officer | Sell | 3,419 | $14.14 | $48K |
| Feb 2, 2026 | Klee Justin B.Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $228K |
| Feb 2, 2026 | Cohen Joshua BCo-Chief Executive Officer | Sell | 15,500 | $14.68 | $228K |
| Feb 2, 2026 | Frates James MChief Financial Officer | Sell | 3,557 | $14.65 | $52K |
| Feb 2, 2026 | Mazzariello GinaChief Legal Officer | Sell | 3,448 | $14.65 | $51K |
| Jan 16, 2026 | Klee Justin B.Co-Chief Executive Officer | Sell | 1,995 | $13.89 | $28K |
| Jan 16, 2026 | Cohen Joshua BCo-Chief Executive Officer | Sell | 1,974 | $13.83 | $27K |
| Jan 15, 2026 | Cohen Joshua BCo-Chief Executive Officer | Sell | 136,193 | $13.59 | $1.9M |
| Jan 15, 2026 | Klee Justin B.Co-Chief Executive Officer | Sell | 136,193 | $13.58 | $1.8M |
| Jan 6, 2026 | Klee Justin B.Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $86K |
| Jan 6, 2026 | Cohen Joshua BCo-Chief Executive Officer | Sell | 7,715 | $11.09 | $86K |
| Jan 6, 2026 | Frates James MChief Financial Officer | Sell | 3,326 | $11.11 | $37K |
| Dec 23, 2025 | Firestone KarenDirector | Buy | 8,100 | $12.45 | $101K |
| Dec 1, 2025 | Bedrosian Camille LChief Medical Officer | Sell | 6,580 | $14.35 | $94K |
| Sep 30, 2025 | Klee Justin B.Co-Chief Executive Officer | Sell | 29,775 | $14.37 | $428K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.